Highline Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.79K | Sell |
168
-226
| -57% | -$10.5K | ﹤0.01% | 370 |
|
|
2025
Q1 | $24K | Buy |
394
+95
| +32% | +$5.79K | 0.01% | 186 |
|
|
2024
Q4 | $16.9K | Buy |
299
+97
| +48% | +$5.48K | 0.01% | 192 |
|
|
2024
Q3 | $10.4K | Buy |
202
+41
| +25% | +$2.12K | ﹤0.01% | 249 |
|
|
2024
Q2 | $6.7K | Buy |
161
+11
| +7% | +$458 | ﹤0.01% | 258 |
|
|
2024
Q1 | $8.14K | Hold |
150
| – | – | ﹤0.01% | 242 |
|
|
2023
Q4 | $7.7K | Buy |
150
+110
| +275% | +$5.64K | ﹤0.01% | 224 |
|
|
2023
Q3 | $2.32K | Hold |
40
| – | – | ﹤0.01% | 268 |
|
|
2023
Q2 | $2.56K | Sell |
40
-47
| -54% | -$3.01K | ﹤0.01% | 216 |
|
|
2023
Q1 | $6.03K | Buy |
87
+47
| +118% | +$3.26K | ﹤0.01% | 174 |
|
|
2022
Q4 | $2.88K | Hold |
40
| – | – | ﹤0.01% | 199 |
|
|
2022
Q3 | $2.84K | Buy |
+40
| New | +$2.84K | ﹤0.01% | 193 |
|